[SHOCKING] FDA Approves Dangerous New Alzheimer’s Drug

The FDA just approved a new drug to treat Alzheimer’s disease. But there’s a huge problem with this… 

And that’s because the drug has shown to be is ineffective, cause significant side effects, and could devastate the Medicare system. 

None of the this is alarmist talk. 

As I’ll show you, it’s written in black and white.  

The drug makers are claiming that this drug will offer hope for patients in the early stages of Alzheimer’s disease. 

That may be true.  

But it’s a false hope based on lies, corruption, and deceit. 

I’ll share with you all the infuriating details about this dangerous new drug — and the government agency that has fallen down on its job. 

The new drug is called Aduhelm, and it’s made by BioGen and Esai. 

It’s a monoclonal antibody drug that targets amyloid beta plaques in the brain. Clumps of these proteins are what build up in the brains of Alzheimer’s patients and lead to damaged brain cells. 

Let me be clear: This new drug did reduce amyloid plaques in clinicals studies.  

But here’s what it didn’t do: 

It didn’t lead to any measurable benefit in cognitive function. 

That’s right: The FDA just approved an Alzheimer’s drug that doesn’t do a thing for Alzheimer’s disease. 

This drug was evaluated in two Phase II clinical trials that included more than 3,000 people with early Alzheimer’s disease and mild cognitive impairment who had amyloid beta plaques in their brains confirmed by brain scans. 

Initially, the studies were stopped early because the drug was unlikely to show clinical benefit. 

After “further evaluation,” the company reversed its findings of the first study and determined that it did in fact delay cognitive decline by 22 percent — which still only amounted to a one-point difference on an 18-point scale. 

The second study saw no statistically significant benefit. 

It gets worse. 

Side effects included temporary brain swelling that led to headaches, confusion, dizziness, vision changes, and nausea. 

And these occurred in 40 percent of the patients! 

Among the most common side effects? Small brain bleeds, falls, delirium, and disorientation. 

That’s just want a dementia patient needs—a drug that causes even more cognitive impairment. 

And yet — and yet! — the FDA still approved this drug. 

What gives? 

It all has to do with a loophole in the FDA’s approval process called the accelerated approval program. It can take years for a drug to go through the approval process — years that an effective drug could be meeting an unmet medical need. 

The idea of the accelerated program is to get an effective drug into the hands of the people it can help, sooner. 

Under this program, a drug or therapy can receive a provisional approval based on what’s called surrogate endpoints… like lowering the HIV viral load or shrinking tumors. 

In this case, the surrogate endpoint is shrinking amyloid beta plaques. 

These drugs still need to undergo further testing to confirm their benefits—but companies have nearly a DECADE to complete it. 

You can bet that most drug companies take their good ol’ time completing further testing so that they can keep raking in the bucks in the event that the FDA rescinds its approval. 

And in the case of Aduhelm, it’s a LOT of bucks. 

This drug costs $56,000 per year, and is administered by IV monthly, which only adds to the cost. 

If just one-third of Americans with Alzheimer’s received this (totally ineffective) drug, healthcare spending could rise by $112 billion per year. 

This is more than the TOTAL Medicare expenditure for ALL prescription drugs purchased in 2020. 

It’s believed that this exorbitant cost could overwhelm Medicare and lead private insurers to restrict coverage or raise premiums. 

The trickle-down effect of this harmful, ineffective drug could be devastating to the entire healthcare system. 

I could go on, but I think you get the point. 

When you or a loved one is facing a heartbreaking, incurable disease like Alzheimer’s, I know how tempting it can be to reach for any shred of hope that’s dangled in front of you. 

But please don’t be duped by this one. 

There is NO true impactful benefit, and it has LOTS of side effects. I’d hate to see you or your loved one put through additional pain and suffering when the only benefit is lining the pockets of the drug company selfish enough to unleash this drug on the population. 

Dr. Richard Gerhauser

P.S. Instead of being tricked into one of Big Pharma’s drugs, there are 6 natural and effective ways to STOP Alzheimer’s. Click here to read about them.